Accelerating drug discovery with analytical R&D solutions

In this interview, Thermo Fisher Scientific discusses how to accelerate drug discovery through analytical R&D.

Related Keywords

Michael Bradley ,Alex Smith ,Patrick Brown ,Mike Bradley ,Karl Fischer ,Sudhir Dahal ,University Of Maryland Baltimore County ,Pennsylvania State University ,Thermo Fisher ,Sponsored Content ,Thermo Fisher Scientific ,Structural Analysisoct ,Raman Product Manager ,Managerthermo Fisher ,Thermo Scientific ,Nanodrop One ,Thermo Scientific Nicolet ,Product Manager ,Advisory Board ,Maryland Baltimore County ,Fisher Scientific ,Pennsylvania State ,Structural Analysis ,Fisher Materials ,Drug Discovery ,Acetaminophen ,Aspirin ,Caffeine ,Fell ,Cell Culture ,Chemicals ,Hromatography ,Compound ,Contamination ,Drugs ,Electron ,Electron Microscopy ,Luorescence ,Forensics ,Ftir Microscopy ,Ormone ,Ibuprofen ,Maging ,Ketamine ,Manufacturing ,Microscope ,Icroscopy ,Olecule ,Oxycodone ,Pharmaceuticals ,Olymers ,Quality Control ,Raman Spectroscopy ,Research ,Na ,Software ,Pectrometry ,Spectrophotometer ,Pectroscopy ,Triage ,Wavelength ,X Ray ,